Caenorhabditis elegans as a model system for human diseases

被引:72
|
作者
Markaki, Maria [1 ]
Tavernarakis, Nektarios [1 ,2 ]
机构
[1] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion 70013, Crete, Greece
[2] Univ Crete, Sch Med, Dept Basic Sci, Iraklion 70013, Crete, Greece
基金
欧洲研究理事会;
关键词
ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; CELL-DEATH; C-ELEGANS; TAU; AGGREGATION; GENETICS; SUSCEPTIBILITY; NEUROTOXICITY;
D O I
10.1016/j.copbio.2019.12.011
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The nematode Caenorhabditis elegans offers unique advantages that enable a comprehensive delineation of the cellular and molecular mechanisms underlying devastating human pathologies such as stroke, ischemia and age-associated neurodegenerative disorders. Genetic models of human diseases that closely simulate several disease-related phenotypes have been established in the worm. These models allow the implementation of multidisciplinary approaches, in addition to large-scale genetic and pharmacological screenings, designed to elucidate the molecular mechanisms mediating pathogenesis and to identify targets and drugs for emergent therapeutic interventions. Such strategies have already provided valuable insights, highly relevant to human health and quality of life. This article considers the potential of C. elegans as a versatile platform for systematic dissection of the molecular basis of human disease, focusing on neurodegenerative disorders.
引用
收藏
页码:118 / 125
页数:8
相关论文
共 50 条
  • [1] Genetic kidney diseases: Caenorhabditis elegans as model system
    Ganner, Athina
    Neumann-Haefelin, Elke
    CELL AND TISSUE RESEARCH, 2017, 369 (01) : 105 - 118
  • [2] Genetic kidney diseases: Caenorhabditis elegans as model system
    Athina Ganner
    Elke Neumann-Haefelin
    Cell and Tissue Research, 2017, 369 : 105 - 118
  • [3] Modeling human diseases in Caenorhabditis elegans
    Markaki, Maria
    Tavernarakis, Nektarios
    BIOTECHNOLOGY JOURNAL, 2010, 5 (12) : 1261 - 1276
  • [4] An in vivo Caenorhabditis elegans model for therapeutic research in human prion diseases
    Bizat, Nicolas
    Parrales, Valeria
    Laoues, Sofian
    Normant, Sebastien
    Levavasseur, Etienne
    Roussel, Julian
    Privat, Nicolas
    Gougerot, Alexianne
    Ravassard, Philippe
    Beaudry, Patrice
    Brandel, Jean-Philippe
    Laplanche, Jean-Louis
    Haik, Stephane
    BRAIN, 2021, 144 : 2745 - 2758
  • [5] Caenorhabditis elegans as a model system for studying the nuclear lamina and laminopathic diseases
    Bank, Erin M.
    Gruenbaum, Yosef
    NUCLEUS, 2011, 2 (05) : 350 - 357
  • [6] Caenorhabditis elegans as a Model System to Study Human Neurodegenerative Disorders
    Roussos, Antonis
    Kitopoulou, Katerina
    Borbolis, Fivos
    Palikaras, Konstantinos
    BIOMOLECULES, 2023, 13 (03)
  • [7] Using Caenorhabditis elegans to fight human neurodegenerative diseases
    Xi Chen
    Brian Kraemer
    Jeff Barclay
    Robert Burgoyne
    Alan Morgan
    Molecular Neurodegeneration, 8 (Suppl 1)
  • [8] Caenorhabditis elegans as a model system for target identification and drug screening against neurodegenerative diseases
    Ma, Liang
    Zhao, Yudan
    Chen, Yuchen
    Cheng, Biao
    Peng, Anlin
    Huang, Kun
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2018, 819 : 169 - 180
  • [9] A Caenorhabditis elegans Model System for Amylopathy Study
    Duan, Zhibing
    Sesti, Federico
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2013, (75):
  • [10] Caenorhabditis elegans: a model system for systems neuroscience
    Sengupta, Piali
    Samuel, Aravinthan D. T.
    CURRENT OPINION IN NEUROBIOLOGY, 2009, 19 (06) : 637 - 643